Guardant Health & Blueprint Medicines present real-world data at IASLC 2022
08 Aug 2022 //
BUSINESS WIRE
InnoCare Announces 1st Subject Dosed in Clinical Trial of TYK2 JH2
01 Aug 2022 //
BUSINESSWIRE
InnoCare`s Clinical Trial of ICP-189 gets approval in China
19 Oct 2021 //
PRNEWSWIRE
Antifungal out, cancer in: Revolution scores $500M Sanofi deal
18 Jul 2018 //
ENDPTS
Exelixis links with BMS to test potential cancer combo
01 Mar 2017 //
PHARMATIMES
BMS buys back early oncology rights from Asia partner
11 Aug 2016 //
FIERCE BIOTECH
Could Common Diabetes Drugs Help Fight Leukemia?
02 Sep 2015 //
WEBB MD
Recall: Baxter`s Clinimix (2015-06-19)
12 Jun 2015 //
HEALTHY CANADIANS